29 results
8-K
EX-99.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
or healthcare privacy and security laws.
Although Tenet may design potential clinical trials for TNT119, CROs will conduct some or all
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
fraud and abuse or false claims laws and regulations or healthcare privacy and security laws.
Although Tenet may design potential clinical trials
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
. The Company has complied in all material respects with all applicable contractual and legal requirements pertaining to information privacy and security … or individual health information, including the Health Insurance Portability and Accountability Act and the standards for the privacy of Individually
8-K
EX-2.1
a8teuz7r
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
10-K
eouwe0x9w0bg3i5hmg
7 Mar 22
Annual report
4:03pm
10-Q
sqa6eqbbxm2n hvfkh
13 Sep 21
Quarterly report
4:01pm
424B4
d1hssvl
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
z18i pmuk
2 Aug 21
IPO registration (amended)
6:08am